Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jun 30;18(6):e0287681. doi: 10.1371/journal.pone.0287681

Behavioral, electrocorticographic and electrocardiologic changes in Colossoma macropomum (Tambaqui) in the effect of cunaniol

Akira Otake Hamoy 1, Suzane Maia da Fonseca 1, Giovanna Lourenço Cei 1, Fábio Leite do Amaral Júnior 1, Maria Klara Otake Hamoy 1, Rafaela Marques Ribeiro 1, Luis Andre Luz Barbas 2, Nilton Muto 3, Moisés Hamoy 1,*
Editor: Pan Li4
PMCID: PMC10313049  PMID: 37390086

Abstract

The Clibadium spp. is a shrub of occurrence in the Amazon, popularly known as Cunambi. The compounds in the leaves demonstrate ichthyotoxic properties, and its major substance, cunaniol, is a powerful central nervous system stimulant with proconvulsant activity. Few current studies relate behavioral changes to the electrophysiological profile of fish poisoning. This study aimed to describe the behavioral, electromyographic, electroencephalographic, electrocardiographic, and seizure control characteristics of anticonvulsant drugs in Colossoma macropomum submitted to cunaniol intoxication during bathing containing 0.3 μg/L cunaniol. The behavioral test showed rapid evolution presenting excitability and spasms, which were confirmed by the analysis of Electroencephalogram (EEG), Electromyogram (EMG), and changes in cardiac function detected in the ECG. Cunaniol-induced excitability control was evaluated using three anticonvulsant agents: Phenytoin, Phenobarbital, and Diazepam. While phenytoin was not effective in seizure control, diazepam proved to be the most efficient. These results demonstrate the susceptibility of Colossoma macropomum to cunaniol poisoning, given that the central nervous system and electrocardiographic changes were considered severe.

Introduction

Plants of the genus Clibadium spp. are popularly known as cunambi are abundantly found in Latin America, mainly in northern and northeastern Brazil [1]. Leaves of this shrub are widely used for predatory fishing, due to their ichthyotoxic properties. The main effects of cunaniol on fish behavior were reported by Quilliam & Stables (1968) [2]. In addition to this ichthyotoxic effect, macerated leaves are used in popular medicine to treat erysipelas, and hemorrhages, as anti-inflammatories, and as a natural insecticide [3].

In relation to its chemical composition, cunaniol (C14H14O2) has as nomenclature: (2R, 3S) -2 - [(Z) -non-1-en-3,5,7-triinyl] oxan-3-ol] following IUPAC (International Union of Pure and Applied Chemistry) rules. It presents a polyacetylene alcohol group that can act as a negative modulator of the GABAA receptor function or as a positive modulator of the GABAA receptor function, particularly those that contain b2 subunits [4].

The seizure effects of cunaniol in fish continue to be researched for their behavioral changes in animals. Costa et al (2006) [5] analyzed the convulsive properties of Clibadium surinamensis extract in Swiss mice and evaluated the excitability of the central nervous system (CNS) caused by the substance. According to Hamoy and colleagues (2018) [6], the treatment with cunaniol in Wistar rats resulted in modifications of the EEG, proving the potent action of this extract as a chemoconvulsant agent with changes in Beta brain oscillations (12 to 28 Hz).

Costa (2006) reported that the molecular mechanism of the CNS excitation caused by oral administration of Clibadium surinamensis extract is not unknown but is blocked by increased activity of GABAA. Still, according to Costa (2006), sodium channels are not directly involved in the toxic activity of the plant, and other possible mechanisms of convulsive effect are also considered, such as the blocking of K+ channels.

The study of antiepileptics to evaluate the blockade of cunaniol-induced seizures should also be highlighted, although little has been elucidated. Of the studies analyzed, diazepam has a better control as a seizure blocker when compared to phenytoin and phenobarbital [5, 6]. As an underexplored subject, a range of investigative possibilities coexist regarding the cunaniol action mechanism, and the use of these drugs might raise hypotheses for its understanding. Thus, this study aims to analyze behavioral and electrophysiological responses in Tambaqui (Colossoma macropomum) induced by cunaniol.

Materials and methods

Experimental animals

The fish used were young forms of tambaqui, Colossoma macropomum, purchased from a fish breeding farm. The animals (20.9 ± 1.5g) were stored in aquariums in the Experimental Biotery of the Pharmacology and Toxicology Laboratory of Natural Products of the Federal University of Pará (UFPA) in a controlled temperature environment (25 to 27.6°C) and photoperiod 12 h L: 12 h D. Feeding was provided twice daily with commercial ration (32% protein) until satiety. Concomitantly with the daily siphoning for the removal of uneaten food and feces, the water was partially renewed (approximately 20% of the volume of the tanks) with water from the same source. During acclimation (15 days), water quality variables such as water temperature (°C); hydrogen potential (pH); dissolved oxygen (DO); ammonia (NH3+), and total hardness were monitored and maintained as follows: Temp. 26.8°C; pH 7.5; DO> 5.0 mg/L; NH3+ 0.1 mg/L and total hardness 70 mg/L CaCO3. A veterinarian (Moisés Hamoy, License CRMV PA1099) monitored (twice a day) the overall clinical health status of the fish batch before and throughout the experiments.

After the trials, all animals (a total of 120 fishes) were euthanized upon administration of propofol at a high dose (30 mg/kg i.p.), as advised by the Brazilian National Council for the Control of Animal Experimentation (CONCEA/Brazil). The decision to euthanize right after the electrophysiological measurements was made by the veterinarian and based on the poor prognosis after the experiment-related handling, surgery and the inexistence of appropriate protocols should they be necessary for analgesia or treatment of potential infections in tambaqui fish. Any suffering that could arise from late convulsions post-exposure to cunaniol, severe inflammation and infection following the removal of the electrodes, or any other pharmacological distress after the experiments could therefore be avoided.

The experiment and all procedures used herein were previously approved by the UFPA Animal Experimentation Ethics Committee: CEUA-UFPA Bio 0101–12.

Cunaniol extraction

Botanical samples of Clibadium spp. were collected in the countryside of Castanhal—PA—Brazil, in a dry land area. Cunaniol was obtained from leaves of the Clibadium surinamense at the Chromatography Laboratory (Institute of Chemistry–Federal University of Para) following the International Guidelines suggested by the World Health Organization (WHO, 2003). The Clibadium tree (known by its popular name Cunambi) has dried samples (exsiccates) in the West Amazon EMBRAPA’S IAN Herbarium (Belém-Pará-Brazil) under registration # 183939.

Cunaniol was handled and protected from light exposure, as it was observed to be a light-sensitive molecule. It was diluted in 0.1% Tween 20 (Sigma-Aldrich) to a concentration of 5 mg/mL and stored at– 20°C, and then diluted to 0.3 μg/L in aquarium water.

Animal groups

Tambaqui juveniles (20.9 ± 1.5g) (120 subjects) were randomly assigned to each EEG and EMG group (n = 12), behavioral and ECG group (n = 9). All groups had contact for 10 minutes with cunaniol (0.3 μg/L) diluted in aquarium water (2000 mL), identified in the following treatments: a) behavioral control group (n = 9) with individuals who had no contact with cunaniol; b) behavioral treated-group (n = 9), with behavioral evaluation during 10 minutes of contact with cunaniol; c) the EEG control group (n = 12) for the electroencephalographic recording group (EEG) composed of animals without contact with cunaniol; d) electroencephalographic recording group (n = 12) during contact with cunaniol; e) EMG control group (n = 12) for electromyographic recording (EMG); f) Electromyographic recording group (n = 12) during contact with cunaniol; g) ECG control group (n = 9) for electrocardiogram (ECG); h) Electrocardiographic recording group (n = 9) in the presence of cunaniol; (i) Diazepam anticonvulsant test group (n = 9); j) Phenytoin anticonvulsant test group (n = 9); l) Phenobarbital anticonvulsant test group (n = 9).

For “i, j, and l” groups, 10 mg/kg of diazepam, phenytoin, and phenobarbital were administered intraperitoneally (IP) ten minutes before contact with cunaniol (0.3 μg/L) and, meanwhile, a 10-minute record was taken to assess the reduction in the onset of central excitability.

Behavioral pattern during contact with cunaniol

Through empirical observation and literature review on behavior analysis, it was adapted to the work, providing classification and description of behaviors, to systematize the results obtained in the experiment upon exposure to 0.3 μg/L cunaniol.

In this study, the following behaviors of Colossoma macropomum exposed to cunaniol were verified taking into consideration the order of appearance of the behavior:

Freezing

The animal stands still. (Freezing)

Excitability (Seizure)

fast movements, swimming without direction, without loss of posture reflex (Circular swimming, horizontal impulses, and rotation around the axis may be present).

Loss of Posture Reflex

The animal cannot maintain its overall pattern of motor activity (back-ventral), sometimes assuming a lateral or ventral-dorsal posture.

Muscle Spasms

decreased normal swimming activity with muscle spasms that become frequent and can propel the fish forward.

Confection and electrode implantation in fish

In this study, the method of Barbas et al. (2021) [7] was used. The electrodes (record and reference) were made with two identical stainless-steel segments measuring 10 mm in length and 0.5 mm in radius (GN INJECTA IND. E COM. LTDA, São Paulo Brazil). Isolated and conjugated with a thin layer of epoxy. The electrodes are conjugated at a distance of 2 mm.

The animals were kept out of the water and fixed in sponges, under a continuous flow of 30 ml of a benzocaine solution at 80 mg/L for anesthesia maintenance. For electroencephalograms, the recording was made in the midbrain region, with electrodes being introduced into the brain along the sagittal line (longitudinal) and caudal edge of the eye (transverse). The intersection location between the lines corresponds to the reference point as ground zero. From this point, they were implanted with 1 mm to the right and 1 mm to the left, after the previous drilling with the dental appliance, conditioned and subsequently fixed with self-curing acrylic. The right side is used as a record and the left side as a reference. After electrode placement, the animals were kept for 48 hours in a recovery aquarium for complete anesthetic metabolism and after preparation, they were placed in an aquarium inside a Faraday cage for recording purposes.

For electromyographic recording, conjugated electrodes were introduced 5.0 mm into the muscle below the dorsal fin, likewise, the animal was placed in aquariums inside Faraday’s cage and subjected to ten minutes of contact with a solution containing 0.3 μg/L of cunaniol.

For cardiac monitoring, the electrodes were constructed of non-welded stainless steel rods with a diameter of 0.3 mm and 5.0 mm in length. The position of fixation of the reference electrode followed the indication of the cardiac vector, being fixed in the ventral part, 0.2 mm after the end of the opercular cavity, and the recording electrode was inserted 2.0 mm below the pectoral fin. Heart rate (BPM), the amplitude of record (mV), QRS duration (S), R-R interval (S), and Q-T duration (S) (Barbas, 2017) were analyzed from the records.

Equipment used to record and data acquisition

The record select rods were connected to one high-impedance amplifier (Grass Technologies, P511) with amplification in 2000x. The voltage records were low-pass filtered at 0.3 kHz and high-pass filtered at 0.3 Hz and monitored by an oscilloscope (Protek, 6510). The data were continuously digitalized and stored at 1kHz sampling resolution at a computer equipped with a board of data acquisition (National Instruments, Austin, TX) stored in a computer hard drive for offline analysis by software (LabVIEW express).

Data analysis

For analysis of the acquired signals, a tool was developed using the Python programming language version 2.7. The NumPy and SciPy libraries were used for the mathematical processing and the matplotlib library for the graphs. The graphic interface was developed using the PyQt4 library.

The amplitude graphs are intended to show the potential difference between the electrodes of reference (left hemisphere) and the record (right hemisphere). In the signal, 1000 samples per second were observed. The spectrograms were calculated using a Hamming window with 256 points (256 / 1000 seconds), and each frame was generated with an overlap of 128 points per window. For each frame, the power spectral density (PSD) was calculated by Welch’s average periodogram method. The frequency histogram was generated by first calculating the PSD of the signal using the Hamming window with 256 points without overlap, with the resulting PSD a histogram was assembled with bins of 1 Hz. To analyze the difference between the experiments, a graph with the mean and standard deviation of PSD of several experiments was assembled, each wave of the graph was generated from a set of experiments, where the individual PSD was calculated and the mean and standard deviation of each group is shown, for calculation of PSD Hamming window of 256 points without superposition was used.

Statistical analysis

After verifying compliance with the assumptions of normality and homogeneity of variance, through the Kolmogorov-Smirnov and Levene tests, respectively, comparisons of the EEG mean power values were made by one-way ANOVA, followed by the Tukey test. For the analysis of the groups for the electrocardiograms, the Student t-test, and the non-parametric test were used. GraphPad Prism® 8 software was used for the analysis. The minimum significance level was set at *p<0.05, **p<0.01, and ***p<0.001 was considered statistically significant in all cases.

Results

No mortalities or disease occurred during acclimation or throughout the experimental period.

Behavioral patterns observed in tambaqui juveniles after contact with cunaniol

During the behavioral characterization experiment, four behaviors were observed that were repeated in all tests and obeyed a chronological order of appearance, initially, the immobility behavior presented a latency of 6.444 ± 4.187 seconds which corresponds to the organism’s first reaction to the exposure site. Behavior evolution occurs rapidly with the animal presenting excitability triggered by a convulsive condition, with an onset latency of 26.00 ± 22.66 seconds. Then there is a loss of posture reflex (64.22 ± 12.50 seconds) and muscle spasms with forwarding impulses (80.11 ± 14.07 seconds). This behavior after its onset was maintained until the end of the 10 minutes of observation.

Cunaniol caused an increase in the EEG amplitude of tambaqui

The animals that did not come into contact with the cunaniol showed uniformity in the EEG, which remained at low amplitude and with more intense energy distribution at frequencies below 10 Hz, as can be seen in Fig 1A. After contact with the cunaniol, the tambaqui juveniles presented alterations in the electroencephalographic records, and two phases of records called potentials bursts can be detected, in which there is an increase in frequency and amplitude with an increased energy distribution up to 50 Hz (Fig 1B), and isolated spikes, with a decrease in the intensity of amplitude and number of shots and energy levels of the record (Fig 1B). The amplitude graph showed that the control had a mean of 0.1139 ± 0.03195 mV2/Hz x 10−3, and the group that came into contact with the cunaniol presented a mean EEG amplitude of 3.845 ± 1.562 mV2/Hz x 10−3, which presented statistical difference to the control. When the saving phase of potentials is analyzed, the mean amplitude was 12.12 ± 2.085 mV2/Hz x 10−3, revealing the component that most increase the amplitude in the register during contact with the cunaniol. In the isolated spikes phase, the mean was 1.740 ± 0.5898 mV2/Hz x 10−3, which showed a significant statistical difference in the recording phases (Fig 2).

Fig 1. Demonstration of the electroencephalographic (EEG) tracing of tambaqui (Colossoma macropomum) in the control (left), 600-second power distribution spectrogram profile (center), 1s amplification of the control EEG (right).

Fig 1

EEG tracing of the mesencephalic region of tambaqui under the action of cunaniol (0.3 μg/L) lasting 600 seconds (on the left), the record shows changes in amplitude and frequency characterized as potential burst and isolated peaks that were amplified to demonstrate the characteristics (left) and a spectrogram demonstrating the energy distribution during contact (lower left quadrant) (B).

Fig 2. Mean amplitudes were recorded during the electroencephalogram (EEG) of Colossoma macropomum juveniles subjected to contact with 0.3 μg/L cunaniol.

Fig 2

Amplitude analysis in the potential bursts and isolated spikes phases. Recordings were made at 600s duration with frequencies up to 50 Hz. [ANOVA and Tukey’s test (n = 12)].

Cunaniol increased electromyographic record amplitude with reduced contact-dependent activity in tambaqui

In the control animals, they presented muscle contractions compatible with normal swimming in the electromyographic register, which remained at low amplitude and with more intense energy distribution at frequencies up to 30 Hz, as can be seen in Fig 3A. After contact with the cunaniol, the tambaqui juveniles presented alterations in the electromyographic records and a period of immobility, excitability (convulsion), and muscle spasms that corroborate the behavioral data observed during excitability, where there is an increase in frequency and amplitude with an increase in energy distribution up to 50 Hz (Fig 3B), and muscle spasms, where there is a decrease in the intensity of amplitude, several shots and energy levels of the record, gradually (Fig 3B). The amplitude graph showed that the control had an average of 16.54 ± 3.096 mV2/Hz x 10−3, and the group that came into contact with the cunaniol presented an average EMG amplitude of 33.32 ± 8.785 mV2/Hz x 10−3, which showed the statistical difference to the control. When the muscular excitability phase is analyzed from the register, the mean amplitude was 53.78 ± 15.34 mV2/Hz x 10−3, the component that most increases the amplitude in the register during contact with the cunaniol. During muscle spasms, the mean was 9.742 ± 2.071 mV2/Hz x 10−3. This result showed no statistical difference for the control group (Fig 4).

Fig 3.

Fig 3

Electromyographic (EMG) records of tambaqui, Colossoma macropomum at baseline (normal swimming) (A), EMG records performed on animals submitted to 0.3 μg/L bath with cunaniol, characterized as a period of intense contraction and increased energy distribution. In magnification, immobility can be proven followed by excitability and muscle spasms (B). Records made in 600 s.

Fig 4. Mean amplitudes were recorded during the electromyogram (EMG) of Colossoma macropomum juveniles subjected to contact with 0.3 μg/L of cunaniol.

Fig 4

Analysis of amplitudes, excitability (convulsion), and muscle spasms. Recordings were made at 600s duration with frequencies up to 50 Hz. [ANOVA and Tukey test (n = 12)].

Cunaniol alters the cardiac function of tambaqui

Taking into consideration the cardiac normal parameters shown Fig 5A and 5B, we measured cunaniol interference during the final 300 seconds of recording 10 minutes of contact in tambaqui due to intense muscle contraction interfering with ECG recording. The C. macropomum under cunaniol influence ECG of is shown in Fig 6A and 6B, and it is possible to identify the P wave, QRS complex, and T wave in the tracing.

Fig 5.

Fig 5

Electrocardiographic recording (ECG) (in the 60s) tambaqui control, Colossoma macropomum with cardiac deflagration demonstrating ECG amplitude (A) and enlarged tracing (in 2s) with the demonstration of P, T waves, QRS complex duration, and amplitude, Q-T and R-R intervals, (B).

Fig 6.

Fig 6

Electrocardiographic recording (ECG) of tambaqui, Colossoma macropomum, and its amplifications during bath with cunaniol at a concentration of 0.3 μg/L, corresponding to the final 300 s of contact with the cunaniol (A). Enlargement of ECG records in 12 seconds demonstrating the components of the record and heart in intense bradycardia (B).

During the period of contact with cunaniol, there was a significant reduction in heart rate (Fig 6A and 6B), and the control group had a mean frequency of 96.22 ± 5.608 (BPM), which showed a statistically significant difference for the cunaniol group with a mean of 23.11 ± 10.02 (BPM) (Table 1).

Table 1. Comparison between heart rate means, in beats per minute (BPM), Amplitude (mV), RR interval (seconds), QT interval (seconds), and QRS duration (seconds) of tambaqui juveniles, Colossoma macropomum, between control and groups in contact with cunaniol 0.3 μg/L (*** indicates differences between control and treated groups indicate significant differences between groups [Test t and Mann-Whitney test (*p <0.05, **p<0.01, ***p<0.001. n = 9)].

Group / Cardiac Activity Heart rate (bpm) Amplitude (mV) R-R interval (s) Q-T interval (s) QRS Duration (s)
Control 96.22 ± 5.608 0.3909 ± 0.07593 0.6084 ± 0.02037 0.2675 ± 0.04457 0.03012 ± 0.001767
Cunaniol 23.11 ± 10.02*** 0.3169 ± 0.03283* 5.487 ± 1.456*** 0.4271 ± 0.06760*** 0.05858 ± 0.008562***

For the amplitude of the records, mean of 0.3909 ± 0.07593 mV was observed for the control group, with a statistical difference for the cunaniol group, which had an average of 0.3169 ± 0.03283 mV, showing impairment in the contraction force of the heart. The R-R interval for the control group with a mean of 0.6084 ± 0.02037 seconds presented a statistical difference for the animals that had contact with cunaniol, with a 5.487 ± 1.456 seconds average. The QT interval that represents ventricular depolarization and repolarization presented a mean for the control group of 0.2675 ± 0.04457 seconds and the cunaniol-treated group presented a mean of 0.4271 ± 0.06760 seconds, which shows that contact with cunaniol increases the time for the treatment to occur repolarization of tambaqui heart. Ventricular depolarization time represented by the QRS duration for the control group was 0.03012 ± 0.001767 seconds and for the cunaniol-treated group, the mean was 0.05858 ± 0.008562 seconds, showing a statistical difference for the control group (Table 1). The group that came in contact with the concentration of 0.3 μg/L cunaniol showed a statistical difference for all parameters (*p <0.05, ***p<0.001).

Diazepam reduces changes in the EEG of the Colossoma Macropomum upon contact with cunaniol

The evaluation of anticonvulsant activity to block the onset of cunaniol-induced seizure outbreaks is shown in Fig 7. The first drug to be tested was diazepam, whose electroencephalographic tracing demonstrated little variation and energy distribution in the spectrogram (Fig 7A). When compared to the control record, which presented an average amplitude of 0.1139 ± 0.03195 mV2 / Hz x 10−3, the diazepam + cunaniol group with an average amplitude of 0.4472 ± 0.2427 mV2 / Hz x 10−3 did not present statistical difference (Fig 8). The phenytoin pretreatment group showed low efficacy to control cunaniol seizures (Fig 7B) and had a mean amplitude of 3.072 ± 1.131 mV2 / Hz x 10−3, showing no statistical difference for the cunaniol group with an amplitude of 3.845 ± 1.562 mV2 / Hz x 10−3 (Fig 8). After phenobarbital application to prevent cunaniol-induced seizure outbreaks, changes in the EEG recordings observed in Fig 7C were observed. The mean amplitude observed in the recordings was 1.656 ± 0.4438 mV2 / Hz x 10−3 and demonstrated statistical differences between the control and cunaniol groups (Fig 8).

Fig 7. Demonstration of the electroencephalographic (EEG) tracing of tambaqui (Colossoma macropomum), its spectrograms and recording amplifications, after application of phenytoin 10 mg/kg i.p.

Fig 7

(A); phenobarbital 10mg/kg i.p. (B) and Diazepam 10mg/kg i.p. (C) followed by an immersion bath with cunaniol to control induced seizures. Records lasting 600 seconds.

Fig 8. Mean amplitude recorded during EEG of Colossoma macropomum juveniles submitted to doses of 10 mg/kg i.p.

Fig 8

of anticonvulsants Diazepam, phenytoin, and phenobarbital 10 minutes before contact with 3 μg/L cunaniol. Recordings were made at 600s duration with frequencies up to 50 Hz. [ANOVA and Tukey test (n = 12)].

Discussion

Behavioral alterations in the species Colossoma macropomum, after contact with cunaniol in the water, varied from immobility, extreme excitability, loss of posture reflex, and muscle spasms. Similarly, Quilliam and Stables (1969) [8] obtained the same result in goldfish and guppies, and Costa et al. (2006) [5] and Hamoy et al. (2018) [6] obtained central excitability behaviors in rats and mice. Other studies that analyzed the behavioral status of animals from experimental convulsive models achieved quite similar repercussions [912], showing that convulsive seizures caused by chemoconvulsants present similarities in behavior patterns.

Evidence of behavioral changes and the elucidation realized from electrophysiological analysis demonstrate the breakdown of homeostasis during contact with substances that alter organic functions [13]. The profile of the waves captured by the electroencephalographic record is subdivided into two main types, which are potential bursts, in which maximum amplitude and frequency are observed, and isolated spikes, characterized by a decrease in frequency and maintenance of the trigger amplitude, being these components found similarly in rats, although firing cycles were not observed [6]. The energy level during the potential bursts (Fig 1B) corresponds to the main element that causes the electrocorticogram to increase the linear scale amplitude (Fig 2).

The electromyographic investigation showed patterns that corroborate the immobility behavior, in which the amplitude of the register is low; the existence of an excitability phase in which amplitude and frequency are increased; and a phase of muscle spasms, which is characterized by rapid contraction, and at this time the animals show loss of posture reflex. Fujimoto et al. (2018) [14], when studying the anesthetic effect of clove oil in 3 Amazonian fish species, showed, in the electromyogram, the period of excitability with muscle hyperactivity and myorelaxation in the induction of anesthetic plan induced by the substance in fish. In induction, hyperactivity is observed followed by decreased swimming activity, loss of balance, and inability to respond to external stimuli [1517]. Such similarity is so pronounced that there is another study that considers cunaniol as an anesthetic inducer [18], although the electrocorticographic recordings confirm the excitatory activity of the CNS. Due to the maintenance of EMG muscle spasms and isolated EEG shots, which are not compatible with anesthetic plans, the possibility of anesthesia is contradicted. Bradycardia could be identified by electrocardiogram, given the decrease in heart rates and amplitude. The increased time required to depolarize and repolarize reiterates this characteristic decrease in the contractile capacity of the heart in Colossoma macropomum (Table 1). In this respect, when related to the seizure picture, changes in cardiac activity in both animals [19] and humans can be evidenced as a result of the autonomic changes caused by seizures [2024]. However, paradoxically, the occurrence of eventual tachycardias is similarly seen and the explanation for this dichotomy is still uncertain [25]. The effect on decreasing or increasing cardiac activity in fish may be related to an indirect action mediated by effects on the central nervous system, which during seizures can activate autonomous mechanisms that may explain these changes.

To evaluate the action of antiepileptics in the control of cunaniol-induced seizures, doses of diazepam, phenytoin, and phenobarbital were administered before contact with cunaniol. Observation of the electrocorticographic findings pointed out that diazepam was the drug that established the most effective in reducing the seizure activity of the chemical agent. Costa et al. (2006) [5] and Hamoy et al. (2018) [6] demonstrated similar results when studying these drugs’ action in inhibiting the CNS’s excitatory characteristics caused by the extract of leaves of the genus Clibadium and cunaniol isolated in mammals.

However, the administration of phenytoin was not effective in controlling seizures caused by cunaniol. Diazepam and phenobarbital have GABAergic agonist activity, which may support the hypothesis of cunaniol acting on GABA-A receptors [5]. Some studies have shown that cunaniol has non-competitive GABA-A receptor antagonist activity [4, 26]. Nevertheless, the full knowledge of its mechanism of action has not yet been fully achieved, which extends, therefore, the potential of pharmacological discoveries of this compound, that may broaden the spectrum of what is known today about seizures, epileptogenic processes, and epilepsy.

The method using electrophysiology to evaluate the toxicity of substances that act on the central nervous system has been increasingly used in fish, this tool helps to partially elucidate the mechanisms of action of certain drugs. Cunaniol triggers excitability in the central nervous system, which is reflected in high-potential muscle contractions, followed by loss of posture reflex. The heart showed a decrease in several parameters, causing cardiac depression in juveniles of Colossoma macropomum. Opening up opportunities for more targeted research in the future to elucidate microscopic and molecular actions

Supporting information

S1 Dataset

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Tseng Y-H, Wang C-M, Peng C-I. Clibadium surinamense L.(Asteraceae): a newly naturalized plant in Taiwan. Taiwania. 2008;53: 103–106. [Google Scholar]
  • 2.Quilliam JP, Stables R. The effect of cunaniol, a polyacetylenic alcohol isolated from the plant Clibadium sylvestre, on piscine behaviour. Br J Pharmacol. 1968;34: 679P. [PMC free article] [PubMed] [Google Scholar]
  • 3.García B. Flora medicinal de Colombia: Botánica médica. 1992. [Google Scholar]
  • 4.Johnston GAR. GABAA receptor pharmacology. Pharmacol Ther. 1996;69: 173–198. doi: 10.1016/0163-7258(95)02043-8 [DOI] [PubMed] [Google Scholar]
  • 5.Costa EA, Rocha FF, Torres MLB, Souccar C, De Lima TCM, Lapa AJ, et al. Behavioral effects of a neurotoxic compound isolated from Clibadium surinamense L (Asteraceae). Neurotoxicol Teratol. 2006;28: 349–353. doi: 10.1016/j.ntt.2006.01.010 [DOI] [PubMed] [Google Scholar]
  • 6.Hamoy M, dos Santos Batista L, de Mello VJ, Gomes-Leal W, Farias RAF, dos Santos Batista P, et al. Cunaniol-elicited seizures: behavior characterization and electroencephalographic analyses. Toxicol Appl Pharmacol. 2018;360: 193–200. doi: 10.1016/j.taap.2018.10.008 [DOI] [PubMed] [Google Scholar]
  • 7.Barbas LAL, Torres MF, da Costa BMPA, Feitosa MJM, Maltez LC, Amado LL, et al. Eugenol induces body immobilization yet evoking an increased neuronal excitability in fish during short-term baths. Aquatic Toxicology. 2021;231: 105734. doi: 10.1016/j.aquatox.2020.105734 [DOI] [PubMed] [Google Scholar]
  • 8.Quilliam JP, Stables R. Action of cunaniol on goldfish. Br J Pharmacol. 1969;35: 382P. [PMC free article] [PubMed] [Google Scholar]
  • 9.JEFFERYS JGR WILLIAMS SF. Physiological and behavioural consequences of seizures induced in the rat by intrahippocampal tetanus toxin. Brain. 1987;110: 517–532. [DOI] [PubMed] [Google Scholar]
  • 10.Cutrufo C, Bortot L, Giachetti A, Manzini S. Differential effects of various xanthines on pentylenetetrazole-induced seizures in rats: an EEG and behavioural study. Eur J Pharmacol. 1992;222: 1–6. doi: 10.1016/0014-2999(92)90454-c [DOI] [PubMed] [Google Scholar]
  • 11.Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O. Kainic acid-induced seizures: dose-relationship of behavioural neurochemical and histopathological changes. Brain Res. 1985;338: 289–295. doi: 10.1016/0006-8993(85)90159-3 [DOI] [PubMed] [Google Scholar]
  • 12.Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behavioural brain research. 1983;9: 315–335. doi: 10.1016/0166-4328(83)90136-5 [DOI] [PubMed] [Google Scholar]
  • 13.Lüttjohann A, Fabene PF, van Luijtelaar G. A revised Racine’s scale for PTZ-induced seizures in rats. Physiol Behav. 2009;98: 579–586. doi: 10.1016/j.physbeh.2009.09.005 [DOI] [PubMed] [Google Scholar]
  • 14.Fujimoto RY, Pereira DM, Silva JCS, de Oliveira LCA, Inoue LAKA, Hamoy M, et al. Clove oil induces anaesthesia and blunts muscle contraction power in three Amazon fish species. Fish Physiol Biochem. 2018;44: 245–256. doi: 10.1007/s10695-017-0430-8 [DOI] [PubMed] [Google Scholar]
  • 15.Vidal LVO, Albinati RCB, Albinati ACL, Lira AD de, Almeida TR de, Santos GB. Eugenol como anestésico para a tilápia-do-nilo. Pesqui Agropecu Bras. 2008;43: 1069–1074. [Google Scholar]
  • 16.Barbas LAL, Stringhetta GR, de Oliveira Garcia L, Figueiredo MRC, Sampaio LA. Jambu, Spilanthes acmella as a novel anaesthetic for juvenile tambaqui, Colossoma macropomum: secondary stress responses during recovery. Aquaculture. 2016;456: 70–75. [Google Scholar]
  • 17.Barbas LAL, Maltez LC, Stringhetta GR, de Oliveira Garcia L, Monserrat JM, da Silva DT, et al. Properties of two plant extractives as anaesthetics and antioxidants for juvenile tambaqui Colossoma macropomum. Aquaculture. 2017;469: 79–87. [Google Scholar]
  • 18.Santos VA dos, BRASIL PR, Malcher CS, CB Lourenço, Trindade GV, Souza RAL de. Anesthetic induction of the aqueous extract of cunambí,“Clibadium Surinamense” linn to perform biometrics in tambaquis,“Colossoma macropomum.” Revista Brasileira de Saúde e Produção Animal. 2016;17: 291–298. [Google Scholar]
  • 19.Mameli O, Melis F, Giraudi D, Cualbu M, Mameli S, De Riu PL, et al. The brainstem cardioarrhythmogenic triggers and their possible role in sudden epileptic death. Epilepsy Res. 1993;15: 171–178. doi: 10.1016/0920-1211(93)90053-a [DOI] [PubMed] [Google Scholar]
  • 20.Devinsky O, Pacia S, Tatambhotla G. Bradycardia and asystole induced by partial seizures: a case report and literature review. Neurology. 1997;48: 1712–1714. doi: 10.1212/wnl.48.6.1712 [DOI] [PubMed] [Google Scholar]
  • 21.Nashef L, Walker F, Allen P, Sander JW, Shorvon SD, Fish DR. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry. 1996;60: 297–300. doi: 10.1136/jnnp.60.3.297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nei M, Ho RT, Sperling MR. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia. 2000;41: 542–548. doi: 10.1111/j.1528-1157.2000.tb00207.x [DOI] [PubMed] [Google Scholar]
  • 23.Tinuper P, Bisulli F, Cerullo A, Carcangiu R, Marini C, Pierangeli G, et al. Ictal bradycardia in partial epileptic seizures: autonomic investigation in three cases and literature review. Brain. 2001;124: 2361–2371. doi: 10.1093/brain/124.12.2361 [DOI] [PubMed] [Google Scholar]
  • 24.Zijlmans M, Flanagan D, Gotman J. Heart rate changes and ECG abnormalities during epileptic seizures: prevalence and definition of an objective clinical sign. Epilepsia. 2002;43: 847–854. doi: 10.1046/j.1528-1157.2002.37801.x [DOI] [PubMed] [Google Scholar]
  • 25.Sevcencu C, Struijk JJ. Autonomic alterations and cardiac changes in epilepsy. Epilepsia. 2010;51: 725–737. doi: 10.1111/j.1528-1167.2009.02479.x [DOI] [PubMed] [Google Scholar]
  • 26.Curtis DR, Johnston GAR. Convulsant alkaloids. Poisons of Plant Origin. 1974; 207–248. [Google Scholar]

Decision Letter 0

Pan Li

17 Feb 2023

PONE-D-22-30736Cunaniol: Behavioral, electrophysiological changes in Colossoma macropomum (Tambaqui)PLOS ONE

Dear Dr. Muto,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Pan Li, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

The study of Cunaniol-induced seizures in fish is very interesting and holds great potential. I hope that the feedback provided below will enhance the quality of the manuscript and increase its chances of acceptance and publication.

Kind regards.

Comments:

Page 1, lines 1-2: “Cunaniol: Behavioral, electrophysiological changes in Colossoma macropomum (Tambaqui)”. I recommend modifying the title of the manuscript to make it clearer.

Page 4, lines 93-94: “In relation to its chemical composition, cunaniol C14H14O2 has as nomenclature: (2R, 3S) -2 - [(Z) -non-1-en-3,5,7-triinyl] oxan-3-ol] following IUPAC rules”. Please enclose the chemical formula of cunaniol in parentheses, and also provide the meaning of the IUPAC acronym (International Union of Pure and Applied Chemistry).

Page 5, lines 103-104: “… potent action of this extract as a chemoconvulsant agent with changes in brain oscillations in Beta (12 to 28 Hz)”. To make the text clearer, I suggest using ‘changes in Beta brain oscillations (12 to 28 Hz)’.

Please correct and standardize the bibliographic references in the text to conform to the journal guidelines for citations (https://journals.plos.org/plosone/s/submission-guidelines#loc-references). For example, in the body of the text, you can cite ‘Costa and colleagues (2006) [corresponding reference number here]…’ (page 5, line 105).

Page 5, line 116: “… to analyze behavioral, and electrophysiological responses in…”. The comma is not necessary.

Page 7, line 166-169: “… and the same tissues were collected for oxidative stress evaluation; (…) at the end of this experiment, muscle, brain and heart tissues were collected to evaluate oxidative stress after contact…”. The results of the experiments measuring oxidative stress are not included in the manuscript. Therefore, I recommend either removing this information from the text or providing an explanation for its intended publication in a future work.

Pages 7 and 8, lines 161-180: Please improve the presentation of the groups treated in each experiment.

Page 11, lines 255-261: Please clearly indicate the statistical analysis used in each performed experiment.

Page 12, line 275: Table 1 is redundant as its information is already detailed in the text.

Page 12, line 277: Replace “electroencephalographic record amplitude” with ‘EEG amplitude’.

Figure 1: In Figures 1A and 1B, there is a correlation between the left and right images (1A = 300 s; 1B = 600 s), hence they should be aligned closely. The images in the center are cutouts of the original tracing of the electrophysiological record. Therefore, it is recommended to place them to the right of the original image, which should have the selected sections clearly marked. In my opinion, Figures 1A and 1B should be arranged in a vertical orientation, with each figure having two columns (similar to Figure 3B), to enhance their visual appeal and make interpretation of the images easier.

Page 14, line 317: “The normal ECG of C. macropomum is shown in Figures 317 6 A and B, ...”. I believe that the normal ECG is displayed in Figure 5.

Page 15, line 355: “… induced seizure outbreaks, changes in the EEG recordings observed in Figure 8 C were…”. The correct figure is 7C.

Figures 3 and 7: I suggest redoing the figures based on the comment about figure 1.

Page 18, line 425: I suggest concluding the discussion with questions and perspectives on the use of this substance in future works.

Finally, I suggest a thorough review of the text to correct errors and improve coherence.

Reviewer #2: The authors should better describe the toxic substance Cunaniol in the introduction.

The authors do not make it clear, whether the effect of cunaniol on bradycardia is direct or indirect?

Cunaniol is an alcohol and could be blocking ionotropic glutamate receptors , why the authors did not test this possibility?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: José Luiz Martins do nascimento

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jun 30;18(6):e0287681. doi: 10.1371/journal.pone.0287681.r003

Author response to Decision Letter 0


2 May 2023

Response to Reviewer’s Comments:

Reviewer #1:

The study of Cunaniol-induced seizures in fish is very interesting and holds great potential. I hope that the feedback provided below will enhance the quality of the manuscript and increase its chances of acceptance and publication.

Kind regards.

Comments:

Page 1, lines 1-2: “Cunaniol: Behavioral, electrophysiological changes in Colossoma macropomum (Tambaqui)”. I recommend modifying the title of the manuscript to make it clearer.

As the reviewer suggested, we modified the title of the manuscript. Line 1.

Page 4, lines 93-94: “In relation to its chemical composition, cunaniol C14H14O2 has as nomenclature: (2R, 3S) -2 - [(Z) -non-1-en-3,5,7-triinyl] oxan-3-ol] following IUPAC rules”. Please enclose the chemical formula of cunaniol in parentheses, and also provide the meaning of the IUPAC acronym (International Union of Pure and Applied Chemistry).

As the reviewer pointed out, we provided the acronym of IUPAC and the chemical composition of cunaniol. Line 94-95.

Page 5, lines 103-104: “… potent action of this extract as a chemoconvulsant agent with changes in brain oscillations in Beta (12 to 28 Hz)”. To make the text clearer, I suggest using ‘changes in Beta brain oscillations (12 to 28 Hz)’.

According to reviewer comments, we corrected “changes in Beta brain oscillations..”

Please correct and standardize the bibliographic references in the text to conform to the journal guidelines for citations (https://journals.plos.org/plosone/s/submission-guidelines#loc-references). For example, in the body of the text, you can cite ‘Costa and colleagues (2006) [corresponding reference number here]…’ (page 5, line 105).

Done.

Page 5, line 116: “… to analyze behavioral, and electrophysiological responses in…”. The comma is not necessary.

Done

Page 7, line 166-169: “… and the same tissues were collected for oxidative stress evaluation; (…) at the end of this experiment, muscle, brain and heart tissues were collected to evaluate oxidative stress after contact…”. The results of the experiments measuring oxidative stress are not included in the manuscript. Therefore, I recommend either removing this information from the text or providing an explanation for its intended publication in a future work.

As the reviewer suggested, we removed the information for oxidative stress evaluation

Pages 7 and 8, lines 161-180: Please improve the presentation of the groups treated in each experiment.

Done.

Page 11, lines 255-261: Please clearly indicate the statistical analysis used in each performed experiment.

Done. Line 258-260

Page 12, line 275: Table 1 is redundant as its information is already detailed in the text.

Page 12, line 277: Replace “electroencephalographic record amplitude” with ‘EEG amplitude’.

Done. Line 277.

Figure 1: In Figures 1A and 1B, there is a correlation between the left and right images (1A = 300 s; 1B = 600 s), hence they should be aligned closely. The images in the center are cutouts of the original tracing of the electrophysiological record. Therefore, it is recommended to place them to the right of the original image, which should have the selected sections clearly marked. In my opinion, Figures 1A and 1B should be arranged in a vertical orientation, with each figure having two columns (similar to Figure 3B), to enhance their visual appeal and make interpretation of the images easier.

As the reviewer suggested, we placed the spectral frequency in the middle.

Page 14, line 317: “The normal ECG of C. macropomum is shown in Figures 317 6 A and B, ...”. I believe that the normal ECG is displayed in Figure 5.

According to reviewer’s comments, we replaced the sentences according to Fig 5 to Fig 6. Line”

315 - 320

Page 15, line 355: “… induced seizure outbreaks, changes in the EEG recordings observed in Figure 8 C were…”. The correct figure is 7C.

Done.

Figures 3 and 7: I suggest redoing the figures based on the comment about figure 1.

Done.

Page 18, line 425: I suggest concluding the discussion with questions and perspectives on the use of this substance in future works.

Done.

Finally, I suggest a thorough review of the text to correct errors and improve coherence.

Reviewer #2:

Comments:

The authors should better describe the toxic substance Cunaniol in the introduction.

Unfortunately, there are still few studies describing Cunaniol and its toxicity. The present study is focusing in elucidate better properties of this Amazonian plant.

The authors do not make it clear, whether the effect of cunaniol on bradycardia is direct or indirect?

As the reviewer suggested, we added the information: “The effect on decreasing or increasing cardiac activity in fish may be related to an indirect action mediated by effects on the central nervous system, which during seizures can activate autonomous mechanisms that may explain these changes.” Line 402 – 405.

Cunaniol is an alcohol and could be blocking ionotropic glutamate receptors , why the authors did not test this possibility?

Our objective was to evaluate the blocking of the anticonvulsant effect with classic drugs (phenobarbital, phenytoin and diazepam). To compare the effects of cunaniol with a glutamatergic agonist.

Previously, we published an in vitro study: “Evaluation of uptake glutamate in cultures of retina cells in the presence of cunaniol”. In that study, the cunaniol was able to block the uptake of glutamate in neuronal cell cultures, confirming that this effect was concentration dependent.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Pan Li

13 Jun 2023

Behavioral, electrocorticographic and electrocardiologic changes in Colossoma macropomum (Tambaqui) in the effect of cunaniol

PONE-D-22-30736R1

Dear Dr. Muto,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Pan Li, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: When resubmitting the manuscript, the authors

included a listing the points

raised by the reviewe, and including both a final

version of the paper and a highlighted version showing

where the changes have been made.

The authors have reviewed the manuscript extensively and is now appropriate to be published.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: José Luiz Martins do Nascimento

**********

Acceptance letter

Pan Li

21 Jun 2023

PONE-D-22-30736R1

Behavioral, electrocorticographic and electrocardiologic changes in Colossoma macropomum (Tambaqui) in the effect of cunaniol

Dear Dr. Muto:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Pan Li

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES